90 related articles for article (PubMed ID: 19028740)
1. Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib.
Chung EJ; Yoo S; Lim HJ; Byeon SH; Lee JH; Koh HJ
Br J Ophthalmol; 2009 Jul; 93(7):958-63. PubMed ID: 19028740
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice.
Kang S; Roh YJ; Kim IB
Exp Eye Res; 2013 Jul; 112():125-33. PubMed ID: 23701975
[TBL] [Abstract][Full Text] [Related]
3. Effect of sorafenib on experimental choroidal neovascularization in the rat.
Park YH; Roh SY; Lee YC
Clin Exp Ophthalmol; 2010 Oct; 38(7):718-26. PubMed ID: 20497436
[
